Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282120
Status:
RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-02-21
Brief Title:
Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FULV Immunotherapy in First-line Gemsitabine Immunoprogressive Patients With Metastatic Biliary Tract Cancer
Sponsor:
Organization:
Tianjin Medical University Cancer Institute and Hospital